Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy

Overview

Journal Curr Angiogenes

Date 2014 Apr 15

PMID 24729954

Citations 32

Authors

James M Dunleavey

Andrew C Dudley

Affiliations

Soon will be listed here.

Abstract

As in normal tissues, solid tumors depend on vascular networks to supply blood, oxygen, and nutrients. Tumor blood vessels are formed by common processes of neovascularization for example endothelial sprouting. However, some tumors have alternative and unexpected mechanisms of neovascularization at their disposal. In a process termed "vascular mimicry," tumors create their own, tumor cell-lined channels for fluid transport independent of typical modes of angiogenesis. These tumor cell-lined conduits may express endothelial-selective markers and anti-coagulant factors which allow for anastamosis with host endothelium. In this review, we explore the current status of vascular mimicry research, highlighting recent evidence which strengthens the hypothesis for this unusual ability of tumor cells. Furthermore, we address the theoretical possibility that vascular mimicry provides a mechanism whereby tumors could escape anti-angiogenic therapies.

Citing Articles

Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives.

Jacobsen A, Siebler J, Grutzmann R, Sturzl M, Naschberger E Cancers (Basel). 2024; 16(5).

PMID: 38473252 PMC: 10930912. DOI: 10.3390/cancers16050890.

Changes in Tissue Fluidity Predict Tumor Aggressiveness In Vivo.

Sauer F, Grosser S, Shahryari M, Hayn A, Guo J, Braun J Adv Sci (Weinh). 2023; 10(26):e2303523.

PMID: 37553780 PMC: 10502644. DOI: 10.1002/advs.202303523.

Pathological angiogenesis: mechanisms and therapeutic strategies.

Dudley A, Griffioen A Angiogenesis. 2023; 26(3):313-347.

PMID: 37060495 PMC: 10105163. DOI: 10.1007/s10456-023-09876-7.

The origins, roles and therapies of cancer associated fibroblast in liver cancer.

Zulaziz N, Chai S, Lim K Front Oncol. 2023; 13:1151373.

PMID: 37035187 PMC: 10076538. DOI: 10.3389/fonc.2023.1151373.

Differential P-Glycoprotein/CD31 Expression as Markers of Vascular Co-Option in Primary Central Nervous System Tumors.

Annese T, Errede M, dAmati A, De Giorgis M, Lorusso L, Tamma R Diagnostics (Basel). 2022; 12(12).

PMID: 36553127 PMC: 9777393. DOI: 10.3390/diagnostics12123120.

References

Jain R, Munn L, Fukumura D . Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer. 2002; 2(4):266-76. DOI: 10.1038/nrc778. View

Francois J, Neetens A . Physico-anatomical studies of spontaneous and experimental intraocular newgrowths: vascular supply. Bibl Anat. 1967; 9:403-11. View

Seftor E, Meltzer P, Kirschmann D, Peer J, Maniotis A, Trent J . Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis. 2002; 19(3):233-46. DOI: 10.1023/a:1015591624171. View

Weeraratna A, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M . Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002; 1(3):279-88. DOI: 10.1016/s1535-6108(02)00045-4. View

Passalidou E, Trivella M, Singh N, Ferguson M, Hu J, Cesario A . Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. Br J Cancer. 2002; 86(2):244-9. PMC: 2375177. DOI: 10.1038/sj.bjc.6600015. View

Conway E, Collen D, Carmeliet P . Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001; 49(3):507-21. DOI: 10.1016/s0008-6363(00)00281-9. View

Spannuth W, Nick A, Jennings N, Armaiz-Pena G, Mangala L, Danes C . Functional significance of VEGFR-2 on ovarian cancer cells. Int J Cancer. 2008; 124(5):1045-53. PMC: 2668132. DOI: 10.1002/ijc.24028. View

van der Schaft D, Hillen F, Pauwels P, Kirschmann D, Castermans K, Oude Egbrink M . Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res. 2005; 65(24):11520-8. DOI: 10.1158/0008-5472.CAN-05-2468. View

Clarijs R, Otte-Holler I, Ruiter D, de Waal R . Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci. 2002; 43(4):912-8. View

10.

Kulesa P, Kasemeier-Kulesa J, Teddy J, Margaryan N, Seftor E, Seftor R . Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci U S A. 2006; 103(10):3752-7. PMC: 1450149. DOI: 10.1073/pnas.0506977103. View

11.

Zhang S, Li M, Gu Y, Liu Z, Xu S, Cui Y . Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma. J Exp Clin Cancer Res. 2008; 27:60. PMC: 2596091. DOI: 10.1186/1756-9966-27-60. View

12.

Hammersen F, Endrich B, Messmer K . The fine structure of tumor blood vessels. I. Participation of non-endothelial cells in tumor angiogenesis. Int J Microcirc Clin Exp. 1985; 4(1):31-43. View

13.

Ellis L, Hicklin D . VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer. 2008; 8(8):579-91. DOI: 10.1038/nrc2403. View

14.

Carmeliet P, Jain R . Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011; 10(6):417-27. DOI: 10.1038/nrd3455. View

15.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

16.

Sharma N, Seftor R, Seftor E, Gruman L, Heidger Jr P, Cohen M . Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate. 2002; 50(3):189-201. DOI: 10.1002/pros.10048. View

17.

Hendrix M, Seftor E, Hess A, Seftor R . Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer. 2003; 3(6):411-21. DOI: 10.1038/nrc1092. View

18.

Sood A, Fletcher M, Zahn C, Gruman L, Coffin J, Seftor E . The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy. Cancer Biol Ther. 2003; 1(6):661-4. DOI: 10.4161/cbt.316. View

19.

Klein W, Wu B, Zhao S, Wu H, Klein-Szanto A, Tahan S . Increased expression of stem cell markers in malignant melanoma. Mod Pathol. 2006; 20(1):102-7. DOI: 10.1038/modpathol.3800720. View

20.

Prause J, JENSEN O . Scanning electron microscopy of frozen-cracked, dry-cracked and enzyme-digested tissue of human malignant choroidal melanomas. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980; 212(3-4):217-25. DOI: 10.1007/BF00410517. View